SeaStar Medical Holding Corporation (NASDAQ:ICU) Short Interest Update

SeaStar Medical Holding Corporation (NASDAQ:ICU) was the target of a significant increase in short interest in February. As of February 13th, there was short interest totaling 286,335 shares, an increase of 85.5% from the January 29th total of 154,400 shares. Approximately 7.6% of the company’s stock are sold short. Based on an average trading volume of 108,978 shares, the short-interest ratio is presently 2.6 days. Based on an average trading volume of 108,978 shares, the short-interest ratio is presently 2.6 days. Approximately 7.6% of the company’s stock are sold short.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Maxim Group set a $6.00 target price on SeaStar Medical in a research note on Thursday, February 12th. Wall Street Zen upgraded shares of SeaStar Medical to a “hold” rating in a research note on Saturday, January 10th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of SeaStar Medical in a research note on Thursday, January 22nd. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has a consensus rating of “Sell” and an average target price of $6.00.

SeaStar Medical Price Performance

Shares of ICU traded up $0.02 during mid-day trading on Friday, reaching $2.76. The company’s stock had a trading volume of 79,738 shares, compared to its average volume of 84,124. The company’s 50 day moving average is $2.46 and its 200 day moving average is $4.85. The stock has a market cap of $10.46 million, a PE ratio of -0.17 and a beta of -1.00. SeaStar Medical has a 12-month low of $2.20 and a 12-month high of $25.70.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Millennium Management LLC purchased a new position in shares of SeaStar Medical in the 3rd quarter valued at $102,000. Jane Street Group LLC acquired a new position in SeaStar Medical in the fourth quarter valued at $30,000. XTX Topco Ltd grew its holdings in shares of SeaStar Medical by 395.4% during the second quarter. XTX Topco Ltd now owns 60,983 shares of the company’s stock worth $26,000 after purchasing an additional 48,674 shares during the last quarter. Finally, Trinity Financial Advisors LLC increased its position in shares of SeaStar Medical by 233.3% during the third quarter. Trinity Financial Advisors LLC now owns 50,000 shares of the company’s stock worth $28,000 after purchasing an additional 35,000 shares in the last quarter. Institutional investors and hedge funds own 1.69% of the company’s stock.

SeaStar Medical Company Profile

SeaStar Medical, Inc (NASDAQ: ICU) is a medical device company focused on the development and commercialization of cerebral embolic protection systems for patients undergoing transcatheter aortic valve replacement (TAVR) procedures. The company’s mission is to reduce the risk of stroke and other neurologic events associated with structural heart interventions by capturing or deflecting embolic debris that can travel to the brain during catheter-based therapies.

The company’s flagship product, TriGUARD® 3, is a next-generation embolic deflection device designed to provide coverage of all three cerebral vessels during TAVR.